Thyme Care

Thyme Care is a Nashville-based value-based cancer care enabler that provides navigation and support to people with cancer or a concern for cancer. Members receive 24/7 telephone and virtual access to a care team that includes medical directors, nurse practitioners, oncology nurses, social workers and Care Partners (community health workers). The team helps members understand diagnoses and treatment plans, find in-network oncologists, manage symptoms and side effects between appointments, arrange transportation, apply for financial assistance, and connect to community and quality-of-life services. Thyme Care does not replace a member's existing oncologist or other clinicians; it coordinates with them and supports their care plans.

The company sells to payers, oncology provider groups, health systems and employers, and positions itself as an integrated oncology infrastructure that aligns incentives across the ecosystem. Member programs include Personalized Cancer Care and Quality-of-Life Care, and its technology stack comprises Thyme Care Connect (member-facing experience), Thyme Care Signal (oncology analytics and insights delivered in the EHR) and Thyme Box (the oncology care delivery platform). Thyme Care Oncology Partners provides deep integration with oncologists. Artificial intelligence is used as an orchestration layer to automate documentation, surface real-time insights and next-step guidance, and synthesize patient data to reduce cognitive load on care teams.

As of September 2025 the company stated it had achieved profitability, managed more than $5 billion in oncology spend, extended access to 8 million people nationwide, and worked with more than 1,000 oncologists. Its website reports 10.5 million covered lives under its risk-bearing partners and partnerships with healthcare organizations in all 50 states.

Founding story

Thyme Care was founded in 2020 by Robin Shah and Dr. Bobby Green, who had previously helped build national oncology infrastructure at Flatiron Health and OneOncology. Working in oncology, the founders were repeatedly asked to help friends and family members after a cancer diagnosis and saw the need for trusted, timely guidance, which led them to build a comprehensive cancer navigation service drawing on oncology and digital health expertise.

Business model

Thyme Care contracts with health plans, employers, oncology practices and health systems under value-based arrangements, taking on accountability for cancer care cost and quality. Services are provided at no cost to eligible individuals insured by partner health plans, with no insurance reimbursement required from the member and no effect on the member's medical plan, costs or coverage.

Revenue derives from partnerships with payers, employers, providers and health systems rather than member fees; the company describes value-based contracts that align incentives with partners, and reported reaching profitability as of September 2025.

Traction

Reported metrics include profitability, more than $5B in oncology spend under management, access extended to 8 million people nationwide, 10.5 million covered lives under risk-bearing partners, more than 1,000 oncologists worked with, ~90% of members reporting feeling more supported, 72% ePRO participation, 40% lower likelihood of ER visits and 19% fewer hospital admissions among members completing ePROs, and nearly 2,000 staff hours saved in a year at one Thyme Care Oncology Partner practice.

Latest developments

In September 2025 Thyme Care announced a $97 million Series D from existing investors CVS Health Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp and Frist Cressey Ventures, joined by new strategic investors Morgan Health, Humana, Texas Oncology and Memorial Hermann Health System. Proceeds are earmarked for expansion across verticals, addressing treatment denials and high drug costs, hiring technology leaders to advance its AI platform and member-facing applications, and adding national and local health plan partnerships. Leadership listed on the company site includes Brad Diephuis, MD as Chief Executive Officer, Bobby Green, MD as Co-Founder, Chief Medical Officer and President, and Robin Shah as Co-Founder and Executive Chairman.